In Vitro Potency and In Vivo Efficacy of a Novel Bis-Indole Antimicrobial Compound in Reducing Catheter Colonization

被引:7
|
作者
Mansouri, Mohammad D. [1 ,2 ]
Opperman, Timothy J. [3 ]
Williams, John D. [3 ]
Stager, Charles [1 ,2 ]
Darouiche, Rabih O. [1 ,2 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Houston, TX USA
[3] Microbiotix Inc, Worcester, MA USA
基金
美国国家卫生研究院;
关键词
STAPHYLOCOCCUS-AUREUS INFECTION; PREVENTION;
D O I
10.1128/AAC.05521-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vascular catheters coated with a novel antimicrobial agent (MBX1631) were studied for their ability to protect against bacterial colonization in vitro and in a rabbit model. MBX1631-coated catheters were significantly less likely to become colonized than control catheters both in vitro and in vivo (P < 0.001). Furthermore, device-associated infection was significantly lower in MBX1631-coated catheters than in uncoated ones (P < 0.005).
引用
收藏
页码:2201 / 2204
页数:4
相关论文
共 17 条
  • [1] A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
    Sunjoo Ahn
    Dong Jin Hwang
    Christina M. Barrett
    Jun Yang
    Charles B. Duke
    Duane D. Miller
    James T. Dalton
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 293 - 304
  • [2] A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
    Ahn, Sunjoo
    Hwang, Dong Jin
    Barrett, Christina M.
    Yang, Jun
    Duke, Charles B., III
    Miller, Duane D.
    Dalton, James T.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 293 - 304
  • [3] Comparative In Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates
    Butler, Michelle M.
    Williams, John D.
    Peet, Norton P.
    Moir, Donald T.
    Panchal, Rekha G.
    Bavari, Sina
    Shinabarger, Dean L.
    Bowlin, Terry L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) : 3974 - 3977
  • [4] Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro
    Kite, P
    Eastwood, K
    Sugden, S
    Percival, SL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) : 3073 - 3076
  • [5] Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs)
    Vargas-Cruz, Nylev
    Rosenblatt, Joel
    Reitzel, Ruth A.
    Chaftari, Anne-Marie
    Hachem, Ray
    Raad, Issam
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [6] In Vitro and In Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma
    Martinez, Tamara
    Victoria Gonzalez, Maria
    Roehl, Ingo
    Wright, Natalia
    Paneda, Covadonga
    Isabel Jimenez, Ana
    [J]. MOLECULAR THERAPY, 2014, 22 (01) : 81 - 91
  • [7] Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model
    Narayana, Jayaram Lakshmaiah
    Mishra, Biswajit
    Lushnikova, Tamara
    Golla, Radha M.
    Wan, Guangshun
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2019, 1861 (09): : 1592 - 1602
  • [8] In vitro enzymatic, in silico ADME and molecular docking based analysis for the identification of novel bis-indole containing triazine-thiazole hybrids derivatives as promising urease inhibitors
    Khan, Shoaib
    Hussain, Rafaqat
    Khan, Yousaf
    Iqbal, Tayyiaba
    Anwar, Saeed
    Aziz, Tariq
    Alharbi, Metab
    [J]. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES, 2024, 79 (7-8): : 195 - 207
  • [9] EP-024297, A Novel and Selective Farnesoid X Receptor Agonist, Exhibits High Potency and Efficacy In Vitro and In Vivo
    Chau, Mary D.
    Li, Yang
    Wang, Guoqiang
    Or, Yat Sun
    Jiang, Lijuan
    [J]. HEPATOLOGY, 2016, 64 : 779A - 780A
  • [10] EDP-305, A Novel and Selective Farnesoid X Receptor Agonist, Exhibits high Potency and Efficacy In Vitro and In Vivo
    Li, Yang
    Chau, Mary D.
    Wang, Guoqiang
    Or, Yat Sun
    Jiang, Lijuan
    [J]. HEPATOLOGY, 2016, 64 : 767A - 767A